Riskpilot← Back to searchSign inGet full accessNyckelöns Psykiatri och Psykoterapi AB
ABDissolvedOrg 5566066667LundMedical specialists activities · NACE 8622Est. 20010 employees
Revenue 2024
SEK 990K
-27% vs 2023
EBITDA margin
7.1%
+294% vs 2023
Equity ratio
56.2%
Financial strength
Net profit 2024
SEK 54K
-88% vs 2023
| Revenue | SEK 990K | -27% |
| EBITDA | SEK 70K | +294% |
| Net profit | SEK 54K | -88% |
| Total assets | SEK 621K | -36% |
| Equity | SEK 349K | -50% |
| Employees | 0 | — |
Legal name
Nyckelöns Psykiatri och Psykoterapi AB
Org number
5566066667
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
23 februari 2001
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Bolaget skall bedriva psykiatrisk och psykologisk verksamhet. Förebyggande och hälsobefrämjande verksamhet. Förvaltning av värdepapper och fast egendom, samt uthyrning av fastigheter och därmed förenlig verksamhet.
Address
Lund
Email
info@bolagspartner.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 842 | 2 521 | 2 481 | 1 358 | 990 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 148 | 559 | 750 | −36 | 70 |
| Depreciation & amort. | −38 | −25 | −57 | −44 | −0 |
| EBIT | 1 110 | 534 | 693 | −80 | 70 |
| Net financials | −17 | −46 | −12 | −3 | — |
| Profit before tax | 822 | 367 | 682 | 559 | 70 |
| Tax | −179 | −87 | −146 | −125 | −16 |
| Net profit | 643 | 280 | 536 | 434 | 54 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 009 | 1 422 | 1 425 | 976 | 621 |
| Equity | 869 | 524 | 661 | 695 | 349 |
| Long-term debt | 99 | 0 | 0 | 0 | 0 |
| Short-term debt | 540 | 257 | 124 | 281 | 273 |
| Total debt | 639 | 257 | 124 | 281 | 273 |
EBITDA margin
7.1%
This company
15.8%
Market median
-55% vs market
20202024
Equity ratio
56.2%
This company
38.2%
Market median
+47% vs market
20202024
Return on equity
15.5%
This company
18.4%
Market median
+16% vs market
20202024
Net profit margin
5.5%
This company
8.1%
Market median
-32% vs market
20202024
Asset turnover
1.59×
This company
1.12×
Market median
+42% vs market
20202024
Debt / equity
0.78×
This company
0.62×
Market median
+26% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
RS Chief Executive Officer | Chief Executive Officer | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2025 | |
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Former (2) | ||
| Chairman | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nyckelöns Psykiatri och Psykoterapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf S Ekholm | Chief Executive Officer | 0 companies |
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Karl-Johan Staffan Tångby | Board of Directors | 0 companies |
| Angela Antonia Maria Simon Risberg | Chairman | 0 companies |
| Björn Tomas Risberg | Deputy Board Member | 0 companies |